OCTA was already shown to be a valuable tool for monitoring neovascular age-related macular degeneration (nAMD), as it clearly displays regression and recurrence/persistence of choroidal neovascularization (CNV) in distinct (sub-) retinal layers in response to anti-vascular endothelial growth factor (VEGF) treatment6, 7. Here, VEGFA is linked to choroidal neovascularization.